A research team has successfully developed the world's first nasal organoid-based SARS-CoV-2 neutralizing antibody evaluation platform.

A Cornell-led collaboration has devised a potentially low-cost method for producing antibodies for therapeutic treatments.

An experimental antibody drug being developed by Jasper Therapeutics in a small early-stage trial allowed children who needed ...

For the first time, Akeso and Summit Therapeutics’ closely watched PD-1xVEGF bispecific antibody has shown that it can extend ...

For years, scientists have hoped to harness the immune system to attack cancer using a group of drugs known as CD40 agonist ...

A phase 1 study has linked Prothena’s anti-amyloid beta antibody to a higher rate of brain swelling than rival approved drugs, hindering the biotech’s positioning in early symptomatic Alzheimer’s ...

In patients with active lupus nephritis, iscalimab shows efficacy in reducing proteinuria and is generally well tolerated.

A modified CD40 antibody shrank or eliminated tumors in six of 12 metastatic cancer patients without the side effects that ...

In a Phase 1 clinical trial of an immunotherapy drug, dubbed 2141-V11, of the 12 patients included, 6 patients saw their tumors shrink, including 2 who saw them disappear completely.

“This study provides compelling evidence that antibody-based therapies can be used to reduce systemic infection and target ...

Fred Hutchinson Cancer Center reports that maternal immunoglobulin G (IgG), ingested in the first week of life, restrained ...